Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry

Journal of Proteome Research

Volumn 9, Issue 4, 2010, Pages 1854-1863

  Rauser, Sandra ^a   Marquardt, Claudio ^a   Balluff, Benjamin ^a,b   Deininger, Sǒren Oliver ^c   Albers, Christian ^c   Belau, Eckhard ^c   Hartmer, Ralf ^c   Suckau, Detlev ^c   Specht, Katja ^d   Ebert, Matthias Philip ^b   Schmitt, Manfred ^b   Aubele, Michaela ^a   Hǒfler, Heinz ^a,d   Walch, Axel ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c BRUKER DALTONIK GMBH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; CRIP1; HER2 testing; MALDI imaging; Molecular classification

Indexed keywords

CYSTEINE DERIVATIVE; CYSTEINE RICH INTESTINAL PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALGORITHM; ARTICLE; BREAST CANCER; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; FRACTIONATION; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY; TISSUE SECTION; VALIDATION STUDY;

ALGORITHMS; BREAST NEOPLASMS; CARRIER PROTEINS; CLUSTER ANALYSIS; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; PEPTIDE FRAGMENTS; PROTEOMICS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 77950661168     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr901008d     Document Type: Article

References (37)

1. Greenlee, R. T.; Murray, T.; Bolden, S.; Wingo, P. A. Cancer statistics, 2000 CA Cancer J. Clin. 2000, 50 (1) 7 - 33 (Pubitemid 30072093)
2. Cornett, D. S.; Reyzer, M. L.; Chaurand, P.; Caprioli, R. M. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems Nat. Methods 2007, 4 (10) 828 - 833 (Pubitemid 350055580)
3. Franck, J.; Arafah, K.; Elayed, M.; Bonnel, D.; Vergara, D.; Jacquet, A.; Vinatier, D.; Wisztorski, M.; Day, R.; Fournier, I.; Salzet, M. MALDI imaging mass spectrometry: State of the art technology in clinical proteomics. Mol. Cell. Proteomics 2009, 8 (9)) 2023 - 33.
4. Lemaire, R.; Menguellet, S. A.; Stauber, J.; Marchaudon, V.; Lucot, J. P.; Collinet, P.; Farine, M. O.; Vinatier, D.; Day, R.; Ducoroy, P.; Salzet, M.; Fournier, I. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker J. Proteome Res. 2007, 6 (11) 4127 - 4134 (Pubitemid 350158491)
5. Schwartz, S. A.; Weil, R. J.; Thompson, R. C.; Shyr, Y.; Moore, J. H.; Toms, S. A.; Johnson, M. D.; Caprioli, R. M. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry Cancer Res. 2005, 65 (17) 7674 - 7681 (Pubitemid 41297241)
6. Villmann, T.; Schleif, F. M.; Kostrzewa, M.; Walch, A.; Hammer, B. Classification of mass-spectrometric data in clinical proteomics using learning vector quantization methods Brief Bioinf. 2008, 9 (2) 129 - 143 (Pubitemid 351516999)
7. Chaurand, P.; Sanders, M. E.; Jensen, R. A.; Caprioli, R. M. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections Am. J. Pathol. 2004, 165 (4) 1057 - 1068 (Pubitemid 39297713)
8. Cornett, D. S.; Mobley, J. A.; Dias, E. C.; Andersson, M.; Arteaga, C. L.; Sanders, M. E.; Caprioli, R. M. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer Mol. Cell. Proteomics 2006, 5 (10) 1975 - 1983 (Pubitemid 44688205)
9. Reyzer, M. L.; Caldwell, R. L.; Dugger, T. C.; Forbes, J. T.; Ritter, C. A.; Guix, M.; Arteaga, C. L.; Caprioli, R. M. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics Cancer Res. 2004, 64 (24) 9093 - 9100 (Pubitemid 39665523)
10. Cazares, L. H.; Troyer, D.; Mendrinos, S.; Lance, R. A.; Nyalwidhe, J. O.; Beydoun, H. A.; Clements, M. A.; Drake, R. R.; Semmes, O. J. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue Clin. Cancer Res. 2009, 15 (17) 5541 - 5551
11. Deininger, S. O.; Ebert, M. P.; Futterer, A.; Gerhard, M.; Rocken, C. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers J. Proteome Res. 2008, 7 (12) 5230 - 5236
12. Hanselmann, M.; Kirchner, M.; Renard, B. Y.; Amstalden, E. R.; Glunde, K.; Heeren, R. M.; Hamprecht, F. A. Concise representation of mass spectrometry images by probabilistic latent semantic analysis Anal. Chem. 2008, 80 (24) 9649 - 9658
13. Hanselmann, M.; Kothe, U.; Kirchner, M.; Renard, B. Y.; Amstalden, E. R.; Glunde, K.; Heeren, R. M.; Hamprecht, F. A. Toward digital staining using imaging mass spectrometry and random forests J. Proteome Res. 2009, 8 (7) 3558 - 3567
14. Schwamborn, K.; Krieg, R. C.; Reska, M.; Jakse, G.; Knuechel, R.; Wellmann, A. Identifying prostate carcinoma by MALDI-Imaging Int. J. Mol. Med. 2007, 20 (2) 155 - 159
15. Wolff, A. C.; Hammond, M. E.; Schwartz, J. N.; Hagerty, K. L.; Allred, D. C.; Cote, R. J.; Dowsett, M.; Fitzgibbons, P. L.; Hanna, W. M.; Langer, A.; McShane, L. M.; Paik, S.; Pegram, M. D.; Perez, E. A.; Press, M. F.; Rhodes, A.; Sturgeon, C.; Taube, S. E.; Tubbs, R.; Vance, G. H.; van de Vijver, M.; Wheeler, T. M.; Hayes, D. F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J. Clin. Oncol. 2007, 25 (1) 118 - 145 (Pubitemid 350003059)
16. Hartmer, R.; Kaplan, D. A.; Gebhardt, C. R.; Ledertheil, T.; Brekenfeld, A. Multiple ion/ion reactions in the 3D ion trap: selective reagent anion production for ETD and PTR from a single compound Int. J. Mass Spectrom. 2008, 276 (2-3) 82 - 90
17. Yanagisawa, K.; Shyr, Y.; Xu, B. J.; Massion, P. P.; Larsen, P. H.; White, B. C.; Roberts, J. R.; Edgerton, M.; Gonzalez, A.; Nadaf, S.; Moore, J. H.; Caprioli, R. M.; Carbone, D. P. Proteomic patterns of tumour subsets in non-small-cell lung cancer Lancet 2003, 362 (9382) 433 - 439 (Pubitemid 36999706)
18. Chivukula, M.; Bhargava, R.; Brufsky, A.; Surti, U.; Dabbs, D. J. Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases Mod. Pathol. 2008, 21 (4) 363 - 368 (Pubitemid 351441033)
19. Villanueva, J.; Shaffer, D. R.; Philip, J.; Chaparro, C. A.; Erdjument-Bromage, H.; Olshen, A. B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; Sanchez-Carbayo, M.; Holland, E. C.; Cordon-Cardo, C.; Scher, H. I.; Tempst, P. Differential exoprotease activities confer tumor-specific serum peptidome patterns J. Clin. Invest. 2006, 116 (1) 271 - 284 (Pubitemid 43121812)
20. Moasser, M. M. Targeting the function of the HER2 oncogene in human cancer therapeutics Oncogene 2007, 26 (46) 6577 - 6592
21. Annecke, K.; Schmitt, M.; Euler, U.; Zerm, M.; Paepke, D.; Paepke, S.; von Minckwitz, G.; Thomssen, C.; Harbeck, N. uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial Adv. Clin. Chem. 2008, 45, 31 - 45
22. Hojilla, C. V.; Wood, G. A.; Khokha, R. Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer Breast Cancer Res. 2008, 10 (2) 205
23. Lopez-Otin, C.; Matrisian, L. M. Emerging roles of proteases in tumour suppression Nat. Rev. Cancer 2007, 7 (10) 800 - 808 (Pubitemid 47463671)
24. Groseclose, M. R.; Massion, P. P.; Chaurand, P.; Caprioli, R. M. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry Proteomics 2008, 8 (18) 3715 - 3724
25. Cheung, K. L. Endocrine therapy for breast cancer: an overview Breast 2007, 16 (4) 327 - 343 (Pubitemid 47109203)
26. Ross, J. S.; Slodkowska, E. A.; Symmans, W. F.; Pusztai, L.; Ravdin, P. M.; Hortobagyi, G. N. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine Oncologist 2009, 14 (4) 320 - 368
27. Cuadros, M.; Villegas, R. Systematic review of HER2 breast cancer testing Appl. Immunohistochem. Mol. Morphol. 2009, 17 (1) 1 - 7
28. Khoo, C.; Blanchard, R. K.; Sullivan, V. K.; Cousins, R. J. Human cysteine-rich intestinal protein: cDNA cloning and expression of recombinant protein and identification in human peripheral blood mononuclear cells Protein Expr. Purif. 1997, 9 (3) 379 - 387 (Pubitemid 27210707)
29. Mackay, A.; Jones, C.; Dexter, T.; Silva, R. L.; Bulmer, K.; Jones, A.; Simpson, P.; Harris, R. A.; Jat, P. S.; Neville, A. M.; Reis, L. F.; Lakhani, S. R.; O?Hare, M. J. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells Oncogene 2003, 22 (17) 2680 - 2688 (Pubitemid 36605615)
30. Tsui, S. K.; Yam, N. Y.; Lee, C. Y.; Waye, M. M. Isolation and characterization of a cDNA that codes for a LIM-containing protein which is developmentally regulated in heart Biochem. Biophys. Res. Commun. 1994, 205 (1) 497 - 505
31. Liu, S.; Stromberg, A.; Tai, H. H.; Moscow, J. A. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells Mol. Cancer Res. 2004, 2 (8) 477 - 487 (Pubitemid 39121510)
32. Ma, X. J.; Salunga, R.; Tuggle, J. T.; Gaudet, J.; Enright, E.; McQuary, P.; Payette, T.; Pistone, M.; Stecker, K.; Zhang, B. M.; Zhou, Y. X.; Varnholt, H.; Smith, B.; Gadd, M.; Chatfield, E.; Kessler, J.; Baer, T. M.; Erlander, M. G.; Sgroi, D. C. Gene expression profiles of human breast cancer progression Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (10) 5974 - 5979 (Pubitemid 36576916)
33. Chen, Y.; Miller, C.; Mosher, R.; Zhao, X.; Deeds, J.; Morrissey, M.; Bryant, B.; Yang, D.; Meyer, R.; Cronin, F.; Gostout, B. S.; Smith-McCune, K.; Schlegel, R. Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Res. 2003, 63 (8) 1927 - 1935 (Pubitemid 36460860)
34. Missiaglia, E.; Blaveri, E.; Terris, B.; Wang, Y. H.; Costello, E.; Neoptolemos, J. P.; Crnogorac-Jurcevic, T.; Lemoine, N. R. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis Int. J. Cancer 2004, 112 (1) 100 - 112 (Pubitemid 39249497)
35. Santin, A. D.; Zhan, F.; Bignotti, E.; Siegel, E. R.; Cane, S.; Bellone, S.; Palmieri, M.; Anfossi, S.; Thomas, M.; Burnett, A.; Kay, H. H.; Roman, J. J.; O?Brien, T. J.; Tian, E.; Cannon, M. J.; Shaughnessy, J., Jr.; Pecorelli, S. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy Virology 2005, 331 (2) 269 - 291 (Pubitemid 40075455)
36. Terris, B.; Blaveri, E.; Crnogorac-Jurcevic, T.; Jones, M.; Missiaglia, E.; Ruszniewski, P.; Sauvanet, A.; Lemoine, N. R. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas Am. J. Pathol. 2002, 160 (5) 1745 - 1754 (Pubitemid 34525654)
37. Wilson, K. S.; Roberts, H.; Leek, R.; Harris, A. L.; Geradts, J. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues Am. J. Pathol. 2002, 161 (4) 1171 - 1185